Metro Healthcare Indonesia (JK:CARE) — Market Cap & Net Worth
Market Cap & Net Worth: Metro Healthcare Indonesia (CARE)
Metro Healthcare Indonesia (JK:CARE) has a market capitalization of $791.02 Million (Rp13.50 Trillion) as of June 17, 2026. Listed on the JK stock exchange, this Indonesia-based company holds position #10149 globally and #97 in its home market, demonstrating a 4.10% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Metro Healthcare Indonesia's stock price Rp406.00 by its total outstanding shares 33250000000 (33.25 Billion). Review Metro Healthcare Indonesia debt and liabilities to assess the company's total debt and financial obligations.
Metro Healthcare Indonesia Market Cap History: 2020 to 2026
Metro Healthcare Indonesia's market capitalization history from 2020 to 2026. Data shows growth from $615.67 Million to $791.02 Million (18.68% CAGR).
Index Memberships
Metro Healthcare Indonesia is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Jakarta Stock Exchange Composite Index
JKSE
|
$485.06 Billion | 0.16% | #95 of 864 |
Weight: Metro Healthcare Indonesia's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Metro Healthcare Indonesia Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Metro Healthcare Indonesia's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
Metro Healthcare Indonesia's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $615.67 Million | $216.30 Billion | $14.31 Billion | 0.00x | 0.04x |
| 2021 | $1.00 Billion | $290.93 Billion | $6.10 Billion | 0.00x | 0.16x |
| 2022 | $927.40 Million | $260.43 Billion | -$93.54 Billion | 0.00x | N/A |
| 2023 | $311.73 Million | $242.68 Billion | -$110.92 Billion | 0.00x | N/A |
| 2024 | $368.23 Million | $319.02 Billion | -$80.31 Billion | 0.00x | N/A |
Competitor Companies of CARE by Market Capitalization
Companies near Metro Healthcare Indonesia in the global market cap rankings as of June 17, 2026.
Key companies related to Metro Healthcare Indonesia by market ranking:
- HCA Healthcare, Inc. (NYSE:HCA): Ranked #327 globally with a market cap of $80.16 Billion USD.
- FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #1003 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
- Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #1050 globally with a market cap of $25.53 Billion USD ( €21.84 Billion EUR).
- IHH Healthcare Bhd (KLSE:5225): Ranked #1333 globally with a market cap of $19.50 Billion USD ( RM77.67 Billion MYR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #327 | HCA Healthcare, Inc. | NYSE:HCA | $80.16 Billion | $396.93 |
| #1003 | FRESENIUS SE+CO. ADR 1/4 | F:FREA | $26.87 Billion | €10.20 |
| #1050 | Fresenius SE & Co. KGaA | XETRA:FRE | $25.53 Billion | €38.77 |
| #1333 | IHH Healthcare Bhd | KLSE:5225 | $19.50 Billion | RM8.79 |
Metro Healthcare Indonesia Historical Marketcap From 2020 to 2026
Between 2020 and today, Metro Healthcare Indonesia's market cap moved from $615.67 Million to $ 791.02 Million, with a yearly change of 18.68%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rp791.02 Million | -40.29% |
| 2025 | Rp1.32 Billion | +259.79% |
| 2024 | Rp368.23 Million | +18.12% |
| 2023 | Rp311.73 Million | -66.39% |
| 2022 | Rp927.40 Million | -7.57% |
| 2021 | Rp1.00 Billion | +62.97% |
| 2020 | Rp615.67 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 17th, 2026 the market cap of Metro Healthcare Indonesia was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $791.02 Million USD |
| MoneyControl | $791.02 Million USD |
| MarketWatch | $791.02 Million USD |
| marketcap.company | $791.02 Million USD |
| Reuters | $791.02 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Metro Healthcare Indonesia
PT Metro Healthcare Indonesia Tbk owns, operates, and manages hospitals in Indonesia. It provides the management of hospitals, clinics, treatment hall, polyclinics, and other medical centers; physical medicine and trading; industry, development, and services; professional, scientific, technical, financial, and investment services; transportation, workshop, forestry, and agriculture services; heal… Read more